Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
Reasons Why You Should Invest in ResMed (RMD) Stock Now
05:04pm, Wednesday, 06'th Jul 2022 Zacks Investment Research
Investors are optimistic about ResMed's (RMD) robust mask and device sales and continued product innovations.
Biogen (BIIB) Lecanemab Gets FDA Priority Tag for Alzheimer's
01:15pm, Wednesday, 06'th Jul 2022 Zacks Investment Research
The FDA sets a target date of Jan 6, 2023 for Biogen (BIIB) and partner Eisai's regulatory filing, which seeks accelerated approval for lecanemab to treat Alzheimer's disease (AD).
Tandem Diabetes (TNDM) New Launches Aid Growth Amid Cost Woes
01:13pm, Wednesday, 06'th Jul 2022 Zacks Investment Research
Tandem Diabetes (TNDM) witnesses strong customer retention, driven by the impressive positive response from the Control-IQ technology.
Bruker (BRKR) International Growth Strong Amid Competition
01:03pm, Wednesday, 06'th Jul 2022 Zacks Investment Research
Bruker (BRKR) Nano Group's microelectronics and semiconductor metrology tools continue to perform well with ongoing strength in bookings and backlog.
The Zacks Analyst Blog Highlights Novo Nordisk, Intel, Qualcomm, T-Mobile US and Sony Group
12:00pm, Wednesday, 06'th Jul 2022 Zacks Investment Research
Novo Nordisk, Intel, Qualcomm, T-Mobile US and Sony Group are part of Zacks top Analyst Blog.
Here's Why Investors Should Retain Charles River (CRL) Now
04:56pm, Tuesday, 05'th Jul 2022 Zacks Investment Research
Investors are optimistic about Charles River's (CRL) strong segmental growth and notable collaborations.
Top Analyst Reports for Novo Nordisk, Intel & Qualcomm
04:13pm, Tuesday, 05'th Jul 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Intel Corporation (INTC), and Qualcomm Inc. (QCOM).
AstraZeneca (AZN) to Buy TeneoTwo, Boost Hematology Pipeline
02:16pm, Tuesday, 05'th Jul 2022 Zacks Investment Research
AstraZeneca's (AZN) acquisition of TeneoTwo is set to add an early-stage T-cell engager to AZN's pipeline. The transaction is likely to close by third-quarter 2022.
Best Momentum Stocks to Buy for July 5th
02:00pm, Tuesday, 05'th Jul 2022 Zacks Investment Research
NVO and TMUS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 5, 2022.
New Strong Buy Stocks for July 5th
11:51am, Tuesday, 05'th Jul 2022 Zacks Investment Research
CHS, PTMN, RYI, NVO and TMUS have been added to the Zacks Rank #1 (Strong Buy) List on July 5, 2022.
Best Momentum Stocks to Buy for July 5th
11:38am, Tuesday, 05'th Jul 2022
NVO and TMUS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 5, 2022.
New Strong Buy Stocks for July 5th
10:06am, Tuesday, 05'th Jul 2022
CHS, PTMN, RYI, NVO and TMUS have been added to the Zacks Rank #1 (Strong Buy) List on July 5, 2022.
Looking for a Growth Stock? 3 Reasons Why Novo Nordisk (NVO) is a Solid Choice
04:45pm, Monday, 04'th Jul 2022 Zacks Investment Research
Novo Nordisk (NVO) could produce exceptional returns because of its solid growth attributes.
LabCorp (LH) to Strengthen Laboratory Footprint in Japan
04:25pm, Monday, 04'th Jul 2022 Zacks Investment Research
LabCorp's (LH) Drug Development arm, in collaboration with BML, will open a 4,000-square meters lab facility in Kawagoe for global clinical trials.
NuVasive (NUVA) to Expand in APAC With New Experience Center
02:34pm, Monday, 04'th Jul 2022 Zacks Investment Research
NuVasive's (NUVA) Singapore Experience Center will complement the flagship Experience Centers in San Diego and the New York metropolitan area.
